- Home
- CR vs ASND Comparison
CR vs ASND Comparison
Compare CR & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CR
- ASND
- Stock Information
- Founded
- CR 1855
- ASND 2006
- Country
- CR United States
- ASND Denmark
- Employees
- CR N/A
- ASND 1017
- Industry
- CR Metal Fabrications
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- CR Industrials
- ASND Health Care
- Exchange
- CR Nasdaq
- ASND Nasdaq
- Market Cap
- CR 8.9B
- ASND 9.1B
- IPO Year
- CR N/A
- ASND 2015
- Fundamental
- Price
- CR $157.58
- ASND $152.15
- Analyst Decision
- CR Strong Buy
- ASND Strong Buy
- Analyst Count
- CR 6
- ASND 14
- Target Price
- CR $174.80
- ASND $201.79
- AVG Volume (30 Days)
- CR 387.9K
- ASND 408.5K
- Earning Date
- CR 04-21-2025
- ASND 05-01-2025
- Dividend Yield
- CR 0.59%
- ASND N/A
- EPS Growth
- CR 13.55
- ASND N/A
- EPS
- CR 5.05
- ASND N/A
- Revenue
- CR $2,131,200,000.00
- ASND $376,478,932.00
- Revenue This Year
- CR $9.75
- ASND $61.43
- Revenue Next Year
- CR $6.67
- ASND $73.07
- P/E Ratio
- CR $33.68
- ASND N/A
- Revenue Growth
- CR 14.45
- ASND 36.34
- 52 Week Low
- CR $128.50
- ASND $111.09
- 52 Week High
- CR $188.52
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- CR 51.10
- ASND 47.92
- Support Level
- CR $147.31
- ASND $143.81
- Resistance Level
- CR $161.47
- ASND $158.45
- Average True Range (ATR)
- CR 4.23
- ASND 6.40
- MACD
- CR 0.56
- ASND -1.83
- Stochastic Oscillator
- CR 72.53
- ASND 32.61
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.